UBS hires RBC Capital biotech bankers in U.S. health-care push
UBS Group AG has hired three investment bankers specializing in biotechnology from RBC Capital Markets as the bank looks to expand its health-care dealmaking in the U.S. Noël Brown will become head of biotechnology at UBS, while Tim Chung and Alex Lim are both joining as managing directors, according to…
Continue Reading
Subscribe to unlock the full article and access premium financial content.
Click here to read the full story: BNN Bloomberg

